| Primary |
| Atrial Fibrillation |
63.0% |
| Cerebrovascular Accident Prophylaxis |
13.3% |
| Cardiac Valve Prosthesis User |
3.6% |
| Anticoagulant Therapy |
3.0% |
| Hypertension |
3.0% |
| Blood Pressure Increased |
1.2% |
| Diabetes Mellitus |
1.2% |
| Dyslipidaemia |
1.2% |
| Hyperlipidaemia |
1.2% |
| Hypothyroidism |
1.2% |
| Lung Disorder |
1.2% |
| Pulmonary Embolism |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
| Arrhythmia |
0.6% |
| Blood Cholesterol |
0.6% |
| Blood Pressure |
0.6% |
| Breast Cancer Metastatic |
0.6% |
| Convulsion |
0.6% |
| Deep Vein Thrombosis |
0.6% |
| Epilepsy |
0.6% |
|
| Cerebrovascular Accident |
13.6% |
| Gastrointestinal Haemorrhage |
9.5% |
| Transient Ischaemic Attack |
9.5% |
| Haemorrhage |
8.2% |
| Ischaemic Stroke |
6.8% |
| Myocardial Infarction |
6.8% |
| Death |
6.1% |
| Cerebral Haemorrhage |
5.4% |
| Renal Failure |
4.1% |
| Renal Failure Acute |
4.1% |
| Dyspnoea |
3.4% |
| Haemorrhage Intracranial |
3.4% |
| Thrombosis |
3.4% |
| Embolic Stroke |
2.7% |
| Haemoglobin Decreased |
2.7% |
| Cardiac Valve Replacement Complication |
2.0% |
| Deep Vein Thrombosis |
2.0% |
| Fall |
2.0% |
| Off Label Use |
2.0% |
| Pain In Extremity |
2.0% |
|
| Secondary |
| Atrial Fibrillation |
35.0% |
| Cerebrovascular Accident Prophylaxis |
28.8% |
| Product Used For Unknown Indication |
7.5% |
| Cardiac Valve Prosthesis User |
5.0% |
| Anticoagulant Therapy |
3.8% |
| Hypothyroidism |
3.8% |
| Blood Pressure Increased |
2.5% |
| Lung Disorder |
2.5% |
| Thrombosis Prophylaxis |
2.5% |
| Breast Cancer Metastatic |
1.3% |
| Depression |
1.3% |
| Diabetes Mellitus |
1.3% |
| Dyslipidaemia |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Hypertension |
1.3% |
| Osteoporosis |
1.3% |
|
| Cerebrovascular Accident |
13.8% |
| Gastrointestinal Haemorrhage |
10.3% |
| Off Label Use |
10.3% |
| Ischaemic Stroke |
6.9% |
| Urticaria |
6.9% |
| Death |
3.4% |
| Embolic Stroke |
3.4% |
| Glomerular Filtration Rate Decreased |
3.4% |
| Haemarthrosis |
3.4% |
| Haematochezia |
3.4% |
| Head Injury |
3.4% |
| Hip Fracture |
3.4% |
| Hyperglycaemia |
3.4% |
| International Normalised Ratio Increased |
3.4% |
| Memory Impairment |
3.4% |
| Pancreatic Carcinoma |
3.4% |
| Pericardial Haemorrhage |
3.4% |
| Platelet Count Abnormal |
3.4% |
| Prostate Cancer Metastatic |
3.4% |
| Rectal Haemorrhage |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
69.2% |
| Rheumatoid Arthritis |
4.7% |
| Osteoporosis |
3.7% |
| Lung Cancer Metastatic |
2.8% |
| Premedication |
2.8% |
| Ankylosing Spondylitis |
1.9% |
| Atrial Fibrillation |
1.9% |
| Dyspnoea |
1.9% |
| Colitis Ulcerative |
0.9% |
| Dyslipidaemia |
0.9% |
| Fluid Overload |
0.9% |
| Gravitational Oedema |
0.9% |
| Hormone Replacement Therapy |
0.9% |
| Hypogammaglobulinaemia |
0.9% |
| Immunosuppression |
0.9% |
| Metastases To Bone |
0.9% |
| Metastasis |
0.9% |
| Neuroendocrine Tumour |
0.9% |
| Osteitis Deformans |
0.9% |
| Pain Management |
0.9% |
|
| Skin Discolouration |
13.6% |
| Blood Glucose Increased |
9.1% |
| Breast Cancer |
4.5% |
| Local Swelling |
4.5% |
| Myocardial Infarction |
4.5% |
| Necrosis Ischaemic |
4.5% |
| Pancreatic Carcinoma |
4.5% |
| Prostate Cancer |
4.5% |
| Pyoderma Gangrenosum |
4.5% |
| Renal Failure |
4.5% |
| Spinal Fracture |
4.5% |
| Streptococcal Infection |
4.5% |
| Sudden Death |
4.5% |
| Tenderness |
4.5% |
| Tremor |
4.5% |
| Urine Odour Abnormal |
4.5% |
| Weight Decreased |
4.5% |
| Wheezing |
4.5% |
| Wound |
4.5% |
|
